Initiator Pharma A/S – Resolutions of the annual general meeting 2026

About this update from Initiator Pharma A/s

Company reg. (CVR) no. 37663808Minutes of the annual general meeting 2026The annual general meeting of Initiator Pharma A/S (the "Company") was held at the offices of DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen OE, Denmark, Friday 29 May 2026, at 10:00 AM CEST.AgendaThe agenda of the annual general meeting was as follows:Appointment of chairman of the meetingThe board of directors’ reportAdoption of the annual reportA resolution to distribute the profit or cover the loss according to the adopted annual reportApproval of the remuneration of the board of directorsElection of members to the board of directorsAppointment of auditorAny proposals receivedPresentation and advisory vote on the Remuneration Report 2025Proposal from the board of directors to amend the authorisation to conduct capital increase with pre-emption rights in article 4a of the Company’s articles of associationProposal from the board of directors to amend the authorisation to conduct capital increase without pre-emption rights in article 4b of the Company’s articles of associationProposal from the board of directors to approve an authorisation for the board of directors to issue warrants with or without pre-emption rights for existing shareholders by inserting a new article 4h in the Company’s articles of associationAuthorisation to the chairman of the meetingAny other businessRe item 1 Appointment of chairman of the general meetingThe general meeting appointed attorney Kristine Hansen (replacing Ulrik Bangsbo Hansen) as the chairman of the general meeting in accordance with the Company’s articles of association.The chairman of the general meeting then established that the general meeting was duly convened and quorate with regard to the agenda in the notice to convene the general meeting. The general meeting was by decision by the board of directors pursuant to the Company’s articles of association conducted in English without simultaneous interpretation from English to Danish.At the general meeting, shareholders representing nominally DKK 1,796,230.17 of the total share capital and 17,106,954 votes were represented, corresponding to approximately 24,99% of the total share capital of nominally DKK 7,187,553.63 and the total number of votes of 68,452,892.The following votes were cast in advance: 6 postal votes.Re item 2 The board of directors’ reportThe board of directors had proposed ...

View stock analysis, news, and events for Initiator Pharma A/s